Navigation Links
Combo Treatment Best for Melanoma, Advanced Ovarian Cancer
Date:2/19/2008

Vaccine plus antibody therapy also produced milder side effects, study finds

TUESDAY, Feb. 19 (HealthDay News) -- Combining periodic infusions of antibodies with a widely used cancer vaccine appears to be more effective and less harsh with melanoma and advanced ovarian cancer patients than using either treatment on its own, a new study shows.

Besides demonstrating the potential usefulness of a vaccine-and-antibody approach, the study -- published online in this week's issue of the the Proceedings of the National Academy of Sciences -- suggests a way of refining treatments even further, based on the biological events that antibody treatment sets in motion.

"We now have a better understanding of how the treatment works -- by increasing the ratio of tumor-killing to immune system-suppressing cells," study author Dr. Stephen Hodi, of Dana-Farber Cancer Institute in Boston, said in a prepared statement. "This suggests techniques for further focusing the immune system to attack the cancer with less 'fallout' for normal tissue."

Previous studies and clinical experience have shown that certain monoclonal antibodies increase the immune system's tumor-destroying activities in some patients but can also give patients serious inflammatory problems, such as severe diarrhea and rashes.

Hodi's research team focused on a molecular receptor on the surface of the immune system's CD4+ T-cells, which guide an attack on infected or cancerous cells. The receptor, known as CTLA-4 (for cytotoxic T lymphocyte-associated antigen), acts as a kind of shut-off valve: When the receptor is stimulated, it causes the T-cells to become inactive, quieting the immune response. Blocking CTLA-4 with a monoclonal antibody offers a way to keep the immune response at full force.

The team looked at a cancer vaccine made from patients' own tumor cells. The tumor cells are irradiated so they stop growing, and a gene in inserted
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Drug Combo Tied to Kidney Risk With Some Cardiac Surgeries
2. Combo Therapy Shows Promise in Treating Brain Tumors
3. Combo Treatment Best for Elderly Lymphoma Patients
4. Combo Therapy Cuts Prostate Cancer Death Rates
5. Drug Combo Halves Death Risk for Severe COPD Patients
6. Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients
7. New Combo Treatment Extends Kidney Cancer Survival
8. Drug Combo With Antibiotic May Slow MS Progression
9. Combo PET/CT Scan Helps Spot Breast Cancers Spread
10. Drug Combos Effective Against Rheumatoid Arthritis
11. Drug Combo Boosts Multiple Myeloma Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Santiago, Chile (PRWEB) June 20, 2013 ... Chile Montaña has put together their winter season ... of outdoor adventure day trips in and around Santiago ... lead trips into Chile's Central Andes for backcountry skiing, ... , For those who have always dreamed of ...
(Date:6/19/2013)... (PRWEB) June 20, 2013 Everyone is looking for ... and inexpensive way to do so. It is called Skin ... - only 5 minutes per day - to improve health and ... improves general health. How? , Skin Brushing improves general health ... it aids the lymphatic system to drain toxins , ...
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Paleo Burn ... thousands of people finally sculpt the body they desire with ... other fat loss programs and health food products, Ken Smith ... and finally give consumers an easy, automatic, and permanent solution ... all the details . , After a quick review of ...
(Date:6/19/2013)... Brand new Hypertrophy Max bonus just released by Vince Del Monte ... Max program. Vince and Ben are only making this bonus ... must act quickly. , What is the all new Hypertrophy Max ... 12 month all access pass to the Live Large TV program ... TV is a Monday night show where over 4,000 members from ...
(Date:6/19/2013)... Shreya Rangarajan of Roland Park Country ... on the future of medicine. , Today, Brandeis ... Summit on the Future of Medicine and has selected ... the state of Maryland at the Summit. , "The ... an environment hard to imagine just a few years ...
Breaking Medicine News(10 mins):Health News:Chile Montaña Announces Winter Season Santiago Day Trips 2Health News:Chile Montaña Announces Winter Season Santiago Day Trips 3Health News:A Fast and Fun Way to Better Skin Quality and Overall Health, says Sublime Beauty® 2Health News:Paleo Burn Review Released by TotalWellnessCleanse.net 2Health News:New Hypertrophy Max Bonus Just Released and Only Available for 24 Hours 2Health News:Global Youth Summit on The Future of Medicine-Shreya Rangarajan selected to represent Roland Park Country School and The State of Maryland 2Health News:Global Youth Summit on The Future of Medicine-Shreya Rangarajan selected to represent Roland Park Country School and The State of Maryland 3
... wonder fish medicine for asthma patients began here Thursday amid ... of people were seen standing in queues for their turn ... offering by Bathini Goud family to avoid any controversy. ... cure for asthma, began at 3.42 p.m., the time fixed ...
... Intel has decided to extend its innovation beyond manufacturing ... to team up with other medical and healthcare companies’ ... and seven others have joined hands to enable high-end ... Health Alliance, led by Intel will seek to effectively ...
... longest working hours in Europe - a reason that is ... study //. ,Stress expert Cary Cooper, of Lancaster University, ... their negative effect on men's health, particularly those working in ... of the Daily Mail. ,Researchers studied 2,200 men ...
... be now treated by a new approach involving release ... with mice by scientists // at John Hopkins Institute ... Medicine. ,The discovery by researchers in Hopkins' ... Genetic Medicine reveals that a protein called GCN5 is ...
... common BP medication during first trimester of pregnancy have ... The Food and Drug Administration reports from data collected ... ,The study, led by William Cooper, M.D., M.P.H., associate ... Hospital at Vanderbilt, found infants born to mothers who ...
... Rajasthan man who has pledged not to marry till he passes ... a wife. He has failed in the examination yet again! // ... Behror town, over 140 km from here, has been taking the ... years of his life, he vowed to marry only after getting ...
Cached Medicine News:Health News:Administration of Fish Drug for Asthma Patients Begins in Andhra 2Health News:Diabetes - New Treatment Approach At John Hopkins 2Health News:Birth Defects Link With ACE Inhibitor Use, FDA Reports 2
(Date:6/19/2013)... Pharmacyclics, Inc. (the "Company") (Nasdaq: ... Journal of Medicine ( NEJM ) published results ... Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in patients with ... ibrutinib may be effective and generally well-tolerated in patients ... separate study examining the safety and efficacy of ibrutinib ...
(Date:6/19/2013)... BRAINTREE, Mass. , June 19, 2013 /PRNewswire/ ... announced several important developments in the pursuit of ... (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) , ... SANM ) for the future production of medical ... , Massachusetts. Sanmina is a leading global provider of ...
(Date:6/19/2013)... 2013 /PRNewswire-iReach/ -- Robert M. Bernstein, M.D., ... procedures and founder of Bernstein Medical – Center ... Doctors, issue of New York Magazine for the ... ) Dr. Bernstein earned his ... reputation as world-renowned hair restoration physician, through a ...
Breaking Medicine Technology:Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 4Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 5Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 6Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 2Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 3
... 27 Kinex Pharmaceuticals will present results from a Phase ... Meeting in Orlando, on May 29, 2009. The study ... (RPCI) and Fox Chase Cancer Center. Dr. Alex Adjei, ... "Results of a phase I trial of KX2-391, a novel ...
... Administered in Dual Cord Blood Transplant for Hematologic MalignancyLA JOLLA, ... announced today that the first patient has been treated ... molecule Stem Cell Modulator (SCM) designed to increase hematopoietic stem ... pathways that guide cell fate. The study, which is ...
Cached Medicine Technology:Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 2Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 3Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 4
Intended for the quantitative determination of magnesium in serum or plasma. Reaction: Endpoint. Wavelength: 520 nm. Linearity: 6.0 mg/dL (2.5 mmol/L)....
For the quantitative determination of Magnesium in serum. Linearity: 4.0 mEq/L. Working Reagent prepared by simple 1:10 dilution....
For the quantitative determination of total glucose in serum....
Glucose reagent is used for the quantitative determination of glucose in human serum....
Medicine Products: